Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells Francesca De AmicisJanagi ThirugnansampanthanSuzanne A. W. Fuqua Preclinical study 17 June 2009 Pages: 1 - 11
Inhibition of pulmonary metastasis in a human MT3 breast cancer xenograft model by dual liposomes preventing intravasal fibrin clot formation Jane WenzelReiner ZeisigIduna Fichtner Preclinical study 23 June 2009 Pages: 13 - 22
Parvovirus H-1 induces cytopathic effects in breast carcinoma-derived cultures Ghaffar MuharramEmilie Le RhunDominique Stehelin Preclinical study 30 June 2009 Pages: 23 - 33
Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer Einar GudlaugssonIvar SkalandJan P. A. Baak Preclinical study 01 July 2009 Pages: 35 - 40
The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer H. ZhangE. A. RakhaA. R. Green Preclinical study 10 July 2009 Pages: 41 - 51
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines Antoinette HollestelleJord H. A. NagelMieke Schutte Preclinical study 11 July 2009 Pages: 53 - 64
Antimitotic chemotherapeutics promote adhesive responses in detached and circulating tumor cells Eric M. BalzerRebecca A. WhippleStuart S. Martin Preclinical study 11 July 2009 Pages: 65 - 78
E-cadherin mediates the aggregation of breast cancer cells induced by tamoxifen and epidermal growth factor Loredana MauroMichele PellegrinoMarcello Maggiolini Preclinical study 11 July 2009 Pages: 79 - 89
Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study Jeanne DebessJens Østergaard RiisMarianne Ewertz Clinical trial 20 March 2010 Pages: 91 - 100
Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial Christian R. LoehbergSebastian M. JudPeter A. Fasching Clinical trial 21 March 2010 Pages: 101 - 110
Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group Trial E3198 Antonio C. WolffMolin WangNancy E. Davidson Clinical trial 24 March 2010 Pages: 111 - 120
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer Carlos H. BarriosMei-Ching LiuMiguel Martin Clinical Trial Open access 26 March 2010 Pages: 121 - 131
Breast cancer risk in women who fulfill high-risk criteria: at what age should surveillance start? Andreas BrandtJusto Lorenzo BermejoKari Hemminki Epidemiology 30 July 2009 Pages: 133 - 141
Breast cancer screening recommendations: dynamic extrapolation of limited data Colin MooneySofia Merajver Invited commentary 10 January 2010 Pages: 143 - 146
Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population Maria A. LoizidouMarios A. CariolouKyriacos Kyriacou Epidemiology 28 August 2009 Pages: 147 - 156
Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations Ke-Da YuGen-Hong DiZhi-Ming Shao Epidemiology 02 September 2009 Pages: 157 - 167
IGF-I during primiparous pregnancy and maternal risk of breast cancer Tianhui ChenAnnekatrin LukanovaEva Lundin Epidemiology 02 September 2009 Pages: 169 - 175
Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis Ni LiJing DongMin Dai Epidemiology 17 September 2009 Pages: 177 - 184
Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk Thomas DünnebierJusto Lorenzo BermejoUte Hamann Epidemiology 17 September 2009 Pages: 185 - 194
GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis Theodoros N. SergentanisKonstantinos P. Economopoulos Epidemiology 17 September 2009 Pages: 195 - 202
Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort N. M. McInerneyN. MillerE. Sawyer Epidemiology 18 September 2009 Pages: 203 - 210
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy Eugenio MaioranoMeredith M. ReganAlan S. Coates Report 12 March 2009 Pages: 211 - 218
A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family Josefa SalgadoJosé M. AramendíaJesús García-Foncillas Report 14 March 2009 Pages: 219 - 220
A novel de novo BRCA2 mutation of paternal origin identified in a Spanish woman with early onset bilateral breast cancer Orland DiezSara Gutiérrez-EnríquezJudith Balmaña Brief Report 01 August 2009 Pages: 221 - 225
Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer Luciane R. CavalliRebecca B. RigginsBassem R. Haddad Brief Report 21 August 2009 Pages: 227 - 231
A novel antiestrogen agent Shikonin inhibits estrogen-dependent gene transcription in human breast cancer cells Yuan YaoQun Zhou Brief Report 18 September 2009 Pages: 233 - 240
Fetal microchimerism in breast from women with and without breast cancer Vijayakrishna K. Gadi Brief Report 19 September 2009 Pages: 241 - 244
Sensitivity analyses including and excluding the HWE-violating studies are required for meta-analyses of genetic association studies C. MaoR. Y. LiaoQ. Chen Letter to the Editor 29 October 2009 Pages: 245 - 246
Some common mutations of RAD50 and NBS1 in western populations do not contribute significantly to Chinese non-BRCA1/2 hereditary breast cancer A-Yong CaoZhen HuZhi-Ming Shao Letter to the Editor 11 November 2009 Pages: 247 - 249
Estrogen receptor regulation: don’t forget translation Laura SmithValerie SpeirsThomas A. Hughes Letter to the Editor 19 November 2009 Pages: 251 - 252
Are PALB2 mutations associated with increased risk of male breast cancer? A. Sauty de ChalonZ. TeoM. C. Southey Letter to the Editor 20 December 2009 Pages: 253 - 255
Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population Eva Esteban CardeñosaPascual Bolufer GilabertEduardo Martínez de Dueñas Letter to the Editor 24 December 2009 Pages: 257 - 260
